Intramembranous bone tissue response to biodegradable octacalcium phosphate implant

Prior research has shown that synthetic octacalcium phosphate (OCP) supports bone formation while undergoing biodegradation more effectively than non-biodegradable hydroxyapatite (HA) in animal models. It was already known that sintered HA ceramic implants do not match the regenerative potential of OCP. That uncertainty drove investigations into how OCP granules behave when implanted in the subperiosteal area of mouse calvaria. No prior work had resolved how OCP compares to non-sintered HA in short-term implantation periods. This gap motivated a closer look at the morphological and histological differences between OCP and HA implants. The biodegradation and bone integration timelines remained unclear for OCP granules. Researchers wanted to determine whether OCP’s biodegradable properties could enhance intramembranous bone formation. The study aimed to clarify how OCP’s structure influences osteogenic activity compared to HA.

The aim of this study was to compare the biodegradable characteristics of synthetic octacalcium phosphate (OCP) granules with non-sintered stoichiometric hydroxyapatite (HA) in the subperiosteal area of mouse calvaria. The researchers wanted to assess how OCP granules influence bone formation in relatively short post-implantation periods. They focused on the structural and functional differences between OCP and HA implants. The motivation came from prior findings that OCP promotes greater bone formation than HA. This study sought to confirm whether OCP’s biodegradable nature supports enhanced osteogenesis. The researchers were particularly interested in the role of alkaline phosphatase activity and osteoclast-like cell interactions. They also aimed to track the long-term integration of OCP granules up to 180 days. The ultimate goal was to determine if OCP could serve as a viable material for augmenting intramembranous bone volume.

The study compared synthetic octacalcium phosphate (OCP) granules with non-sintered hydroxyapatite (HA) in mouse calvaria. Researchers implanted granules in the subperiosteal area and monitored outcomes over time. They used element analysis to track calcium and phosphorus levels in newly formed bone. Histomorphometric analysis was conducted to measure bone formation and osteoclast activity. Tartrate-resistant acid phosphatase (TRAP) staining identified osteoclast-like cells interacting with the implants. Scanning electron microscopy revealed the morphological differences between OCP and HA granules. The study evaluated implantation periods ranging from 21 to 180 days. Researchers focused on the structural characteristics of OCP and HA, including pore volume and granule morphology.

OCP granules showed a plate-like morphology, while HA granules had a sphere-like structure. Both materials had pore volumes exceeding 75%, with micropores within granules. Element analysis revealed direct bonding of new bone to HA up to 35 days post-implantation. Histomorphometric data indicated greater bone formation on OCP surfaces than on HA up to 21 days. OCP surfaces exhibited higher alkaline phosphatase activity compared to HA surfaces. Tartrate-resistant acid phosphatase (TRAP) positive osteoclast-like cells attacked OCP surfaces more than HA. By 180 days, OCP granules were encapsulated and replaced by new bone. These findings suggest that OCP’s biodegradable nature supports enhanced intramembranous bone formation.

The authors suggest that the biodegradable nature of octacalcium phosphate (OCP) granules may enhance intramembranous bone formation in mouse calvaria. They propose that OCP supports greater osteogenic activity than non-sintered hydroxyapatite (HA). The study indicates that OCP surfaces facilitate more bone formation and higher alkaline phosphatase activity than HA. The increased interaction with TRAP-positive osteoclast-like cells suggests OCP is more biodegradable than HA. Encapsulation and replacement of OCP granules with new bone over 180 days support its potential for bone augmentation. These findings align with prior observations that OCP outperforms HA in bone regeneration. The results may suggest that OCP could serve as an effective implant material for intramembranous bone volume augmentation. The authors emphasize the importance of OCP’s structural and biodegradable properties in promoting bone formation.